State Street’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
CAM
TGA
LCM
NCM
PBPIA
5VM
AC
State Street's RLYB Position: Q1 2026 in Review
State Street sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 7,759 shares — an estimated $42.6K sold.
State Street first reported a position in RLYB in Q3 2021 and held it in 18 quarters. The position peaked at $3.65M in Q3 2022. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.
- State Street reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
- State Street sold 7,759 Rallybio shares in Q1 2026, an estimated $42.6K.
- State Street first reported a position in Rallybio in Q3 2021 and held it in 18 quarters.
- State Street's Rallybio position peaked at $3.65M in Q3 2022.
- 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.